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Currently there is a growing interest in screening of new drugs, capable of destroying cancer cells 
effectively, without damaging health tissues. In this context the potential of liposomes as a drug carrier 
system is extensively investigated [1-3]. Liposomes are nanosize particles in which lipid bilayer encloses 
an aqueous internal compartment. Size, charge and surface properties of liposomes can be easily changed 
simply by adding new ingredients to the lipid mixture before liposome preparation or by variation of 
preparation techniques. Another important feature is that lipid vesicles can entrap both hydrophilic and 
hydrophobic pharmaceutical agents. Liposome delivery systems can enhance drug solubility, reduce 
toxicity associated with free anticancer drugs and improve stability of the drug by protecting the 
compound from chemical degradation or transformation. However, the therapeutic and toxic effects of 
drug are strongly determined by the degree or efficiency of its loading into the liposomes. For this reason, 
while using liposomes as delivery systems for hydrophobic drugs, it is necessary to know the character of 
a drug effect on the structure and physicochemical properties of a lipid bilayer. The aim of this work was 
to investigate the effect of lipid composition on membrane interactions of europium coordination 
complexes, V3 and V4, the potential antineoplastic drugs. Liposomes were formed by egg yolk 
phosphatidylcholine (PC) and its mixture with cardiolipin (CL) and cetyltrimethylammonium bromide 
(CTAB). The membrane-partitioning properties of the investigated drugs were evaluated using the 
equilibrium dialysis technique in combination with absorption spectroscopy. To gain insight into the drug 
influence on physical parameters and molecular organization of lipid bilayer, two fluorescent probes have 
been employed, viz. pyrene and 1,6-diphenyl-1,3,5-hexatriene (DPH). It was found that inclusion of 
anionic lipid cardiolipin and cationic detergent CTAB into PC bilayer gives rise to decrease of the drugs 
partition coefficients. The drug incorporation into liposomal membrane is accompanied by the alterations 
of pyrene spectral parameters and DPH anisotropy. The observed effects suggest that the influence of 
europium compounds on bilayer structural state can be modulated by CL and CTAB.  
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Over the past decades, the concept of liposome use for the delivery of antineoplastic 
drugs has gained increasing interest. Liposomes are spherical self-closed particles, consisting 
of a bilayer enclosing an aqueous compartment. For drug payload purposes liposomes are 
commonly prepared from phospholipids, cholesterol, cholesterol esters and triglycerides. 
Owing to biodegradable and biocompatible nature of liposomal constituents such lipid 
nanocarriers offer a number of advantages making it an ideal drug delivery vehicle. The 
amphiphilic character of lipid vesicles enables encapsulation of both hydrophobic and 
hydrophilic compounds. However, similar to other carrier systems, the use of liposomes in 
drug delivery also has disadvantages and difficulties. One of them concerns their chemical 
and biological stability. The stability of liposomal formulations is largely determined by the 
drugs membrane-partitioning properties as well as by physicochemical characteristics of the 
lipid vesicles [1-3]. The present study was undertaken to evaluate the effect of lipid 
composition on membrane interactions of the new potential antineoplastic drugs europium 
coordination complexes (EC), referred here to as V3 and V4.  
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MATERIALS AND METHODS 
Egg yolk phosphatidylcholine and beef heart cardiolipin were purchased from Biolek 
(Kharkov, Ukraine). DSP-12 was obtained from Zonde (Latvia), pyrene, DPH and CTAB 
were from Sigma (Germany). Eu(III) coordination complexes (Fig. 1) were synthesized as 
described previously [4]. Lipid vesicles composed of PC and its mixtures with CL and CTAB 
were prepared using the extrusion technique [5]. The thin lipid film was obtained by 
evaporation of lipids’ ethanol solutions and then hydrated with 1.2 ml of 5 mM Na-phosphate 
buffer (pH 7.4). Lipid suspension was extruded through a 100 nm pore size polycarbonate 
filter. Phospholipid concentration was determined according to the procedure of Bartlett [6]. 
Absorption measurements were conducted using SF-46 spectrophotometer. Fluorescence 
measurements were performed with CM 2203 spectrofluorimeter equipped with magnetically 
stirred, thermostated cuvette holder (SOLAR, Belarus). Pyrene fluorescence measuring was 
recorded under the following conditions: pyrene concentration – 22 μM, V3 and V4 
concentrations – 0.49 and 0.36 μM in PC:CL liposomes, 2.8 and 0.35 μM in PC:CTAB, 
respectively. Lipid concentration was 0.16 mM. While measuring DPH anisotropy, the 
concentrations employed were: DPH – 4μM, lipid – 0.15 mM, V3 and V4 – 7.1 and 5.1 μM in 
PC:CL liposomes, 2.8 and 0.35 μM in PC:CTAB, respectively.  
 
RESULTS AND DISCUSSION 
Efficient and stable encapsulation of 
drugs is one of the most difficult tasks in the 
development of liposomal drug formulations. 
At the first step of the study we focused on 
investigation of EC partitioning into the lipid 
bilayer. To evaluate the lipid association 
ability of the drugs in questions the 
equilibrium dialysis technique was used. This 
method is based on the diffusion of small 
molecules through a semi-permeable 
d of two chambers separated by cellulose 
membrane. One half-cell is filled with the buffer and the other half-cell with the drug solution 
or drug-liposome mixture. In our experiments the volume of liquid in each compartment was 
3 ml. The loading of dialysis cells was made as follows: 3 mL of the buffer solution were 
placed on one side of the membrane (compartment 1) and 3 mL of drug-lipid mixture, 
containing 2.7 ml of liposomes (lipid concentration – 0.9 mM) and 0.3 ml of the investigated 
drugs (V3 and V4 concentration were 4.8×10-5M, 3.5×10-5M in PC and PC:CL liposomes, 
respectively, V3 concentration in PC:CTAB – 6.4×10-5M), on the other side (compartment 2). 
After the equilibrium was established, the V3 and V4 concentrations in the solution from the 
first compartment were determined by absorption spectroscopy, using extinction coefficients 
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Fig. 1. Structure of europium coordination 
complexes. 
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T artable 1. P ition coefficients of europium coordination complexes in different lipid systems 
 PC ) PC:CL(20%) PC:CTAB(5%
V3 5×104 ± 1.5×104 1.3×104 ± 3.9×103 1.9×104 ± 5.7×103 
V4 3.2×104 ± 9.6×103 3.2×103 ± 9.6×102 not determined 
 
As seen f  the   high aine er study, 
suggestin e e sulat al me data are in 
ood accordance with our previous results obtained for PC and PC-cholesterol liposomes. It 
rom Table 1, relatively  Kp values were obt d for all systems und
g th fficient drug encap ion into the liposom mbrane. These 
g
seemed also of interest to compare the Kp values recovered for neat PC, PC:CTAB and PC:CL 
model membranes. The inclusion of anionic lipid cardiolipin and cationic detergent CTAB 
into PC bilayer gives rise to decrease of EC partition coefficients. This finding suggests that 
CL and CTAB molecules can limit the drug partitioning into the lipid phase. One of the 
possible reasons for such limitation may include modification of lipid packing by CL and 
CTAB molecules. [9] 
At the next step of this study the bilayer-modifying properties of V3 and V4 were 
evaluated using fluorescent probes pyrene and DPH. Pyrene is one of the most commonly 
used membrane probes. It allows investigation of the membrane dynamic properties and its 
polarity. The fluorescence spectra of this probe possess a well defined vibrational band 
structure between 370 and 400 nm (monomer emission), and a characteristic peak around 465 
nm (excimer emission). The relative intensities of the first and third vibronic peaks (II/IIII, 
where II and IIII are fluorescent intensities at 374 and 384 nm, respectively) undergo 
significant changes upon going from nonpolar to polar solutions being a polarity-sensitive 
parameter. In particular, II/IIII increases from 0.64 to 1.45 on going from cyclohexane to 
ethanol; in water, II/IIII = 1.95 [10].  
As was found in our previous study the intensity ratio of the first to the third pyrene 
vibronic bands [10], remains virtually unchanged upon V3 and V4 association with PC, and 
PC:Chol vesicles. similar behavior of II/IIII ratio was observed in PC:Cl and PC:CTAB 
systems (Table 2). In this context it is interesting to draw attention to the fact that II/IIII values 
observed in our experiments correspond to the intensity ratio of pyrene vibronic bands in a 
hydrophobic environment. These results corroborate our assumption that EC do not affect the 
distribution of pyrene monomers and exert no influence on polarity of lipid bilayers. 
 
Table 2. Effect of europium coordination complexes on pyrene spectral parameters in different 
lipid-drug systems.  
Without V3 +V3 Without V4 +V4 Liposome  
composition /I IIII I  /I IIII I  /I IIII I  /I IIII I  
PC 1.04 1.02 1.04 1.04 
PC:CL(5%) 1.02 1.01 1.02 1.01 
PC:CL(20%) 1.03 0.98 1.03 0.65 
PC 0.97 0.91 0.87 0.9 
PC:CTAB(5%) 0.92 0.94 0.87 0.86 
P  C:CTAB(10%) 0.94 0.91 0.91 0.87 
 
On the contrary, EC incorporation into the lipi e of mo embranes brings about 
the changes of another parameter under examinatio yrene ex on intensity 
ratio E/M e rate of  lateral ion with embrane plane (Fig 
2). It was found that both V3 and V4 reduce E/M in PC:CL liposomes (Fig. 1, A). The same 
d phas del m
n – p
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cimer-to-m
in the m
omer 
 ( ) which reflects th  probe
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effect was observed for V3 in PC:CTAB liposomes (Fig. 1, B), while in V4+PC:CTAB 
system no significant E/M changes were detected. These results indicate that EC 
incorporation into liposomal membrane is accompanied by the restriction of pyrene lateral 
diffusion, which in turn, may reflect the reduction of lipid bilayer free volume.  
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Fig. 2. Effect of europium coordination complexes on pyrene spectral parameters: A) PC:CL, and B) PC:CTAB 
lipid vesicles.  
 
These data seem to be contradict th lts of DPH anisotropy measurements. 
g the excited-state lifetime. In other words, anisotropy value is inversely 
roportional to the probe rotation rate: the smaller is anisotropy value, the faster probe rotates.  
e resu
Polarization and anisotropy of this probe are defined by the extent to which its fluorophore 
rotates durin
p
 
Table 3. The change of DPH anisotropy induced by europium coordination complexes, %.  
Investigated  
systems 
CL(5%) CL(10%) CL(20%) CTAB(5%) CTAB(10%) 
V3 -13.8% -13.5 -8.5 -10.6 -22 
V4 +36.4 +45 +51.8 -9.7 -31.9 
 
As shown in the Table 3 EC inclusion into PC:CTAB liposomes were followed by the 
decreas  DPH ani In ng w r prev esults o ed for PC:Chol 
liposom he observ rep in pyr  DP ta may be explained by the 
difference in the mechanisms by which these probes respond to the alterations in their 
e of sotropy.  keepi ith ou ious r btain
es t ed disc ancy ene and H da
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micr
 information about cardiolipin 
and cetyltrimethylammonium bromide effect on membrane interactions of the drugs in 
question can be used in the designing of omal formulations.  
/007). 
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 of human malignant cell lines // 
s of defined size // Meth. Enzymol. 
sic amino acids // Biophys. J. – 1997. – V. 72. – P. 794-805. 
f length of acyl chains, carbonyl group of lipids and biomembrane 
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ctural state of model membranes as 
oenvironment. While the changes in pyrene excimerization arise from the modifications 
in probe lateral movements, variations in DPH anisotropy mirrors the changes in probe 
rotational mobility. However it should be noted that the opposite changes of DPH anisotropy 
were observed – decrease for V3 to and increase for V4. Opposite behaviour of V3 and V4 in 
CL liposomes can be interpreted in terms of both distinctions in EC structure and different 
pattern of their interaction with the given type of lipid bilayer. 
 
CONCLUSIONS 
The results of the present study confirm the possibility of incorporation of europium 
coordination complexes into the lipid vesicles. The obtained
 their effective lipos
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